Author:
Hajiran Ali,Azizi Mounsif,Aydin Ahmet M.,Chakiryan Nicholas H.,Peyton Charles C.,Boulware David C.,Manley Brandon J.,Gilbert Scott M.,Sexton Wade J.
Publisher
Springer Science and Business Media LLC
Reference31 articles.
1. Surveillance Epidemiology and End Results (SEER) Program. Cancer Stat Facts: Testicular Cancer 2019 https://seer.cancer.gov/statfacts/html/testis.html. Accessed August 5, 2019.
2. Pierorazio PM, Albers P, Black PC, et al. Non-risk-adapted surveillance for stage I testicular cancer: critical review and summary. Eur Urol. 2018;73(6):899–907.
3. Kollmannsberger C, Moore C, Chi KN, et al. Non-risk-adapted surveillance for patients with stage I nonseminomatous testicular germ-cell tumors: diminishing treatment-related morbidity while maintaining efficacy. Ann Oncol. 2010;21(6):1296–301.
4. Daugaard G, Gundgaard MG, Mortensen MS, et al. Surveillance for stage I nonseminoma testicular cancer: outcomes and long-term follow-up in a population-based cohort. J Clin Oncol. 2014;32(34):3817–23.
5. Wein AJ, Kavoussi LR, Campbell MF. Campbell–Walsh urology uro-oncology. 1st edn. Philadelphia, PA: Elsevier Saunders; 2015.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献